Article Text

Download PDFPDF

Short report
Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head
  1. Wayne Mah1,
  2. Swapnil K Sonkusare2,3,
  3. Tracy Wang1,
  4. Bouziane Azeddine1,
  5. Mihaela Pupavac4,
  6. Jian Carrot-Zhang4,5,
  7. Kwangseok Hong3,
  8. Jacek Majewski4,5,
  9. Edward J Harvey6,
  10. Laura Russell4,
  11. Colin Chalk7,
  12. David S Rosenblatt4,
  13. Mark T Nelson2,8,
  14. Chantal Séguin1
  1. 1Division of Hematology and Oncology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
  2. 2Department of Pharmacology, University of Vermont, Burlington, Vermont, USA
  3. 3Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA
  4. 4Department of Human Genetics, McGill University, Montreal, Quebec, Canada
  5. 5Department of Human Genetics, McGill University and Genome Québec Innovation Centre, Montreal, Quebec, Canada
  6. 6Department of Surgery, Division of Orthopaedic Surgery, McGill University Health Centre, Montreal, Quebec, Canada
  7. 7Department of Neurology & Neurosurgery, McGill University, Montreal, Quebec, Canada
  8. 8Institute of Cardiovascular Sciences, University of Manchester, Manchester, UK
  1. Correspondence to Dr Chantal Séguin, McGill University Health Centre, 1001 Décarie Blvd., D02-7519, Montreal, Quebec, Canada H4A 3J1; chantal.seguin2{at}mcgill.ca

Abstract

Background Osteonecrosis of the femoral head is a debilitating disease that involves impaired blood supply to the femoral head and leads to femoral head collapse.

Methods We use whole-exome sequencing and Sanger sequencing to analyse a family with inherited osteonecrosis of the femoral head and fluorescent Ca2+ imaging to functionally characterise the variant protein.

Results We report a family with four siblings affected with inherited osteonecrosis of the femoral head and the identification of a c.2480_2483delCCCG frameshift deletion followed by a c.2486T>A substitution in one allele of the transient receptor potential vanilloid 4 (TRPV4) gene. TRPV4 encodes a Ca2+-permeable cation channel known to play a role in vasoregulation and osteoclast differentiation. While pathogenic TRPV4 mutations affect the skeletal or nervous systems, association with osteonecrosis of the femoral head is novel. Functional measurements of Ca2+ influx through mutant TRPV4 channels in HEK293 cells and patient-derived dermal fibroblasts identified a TRPV4 gain of function. Analysis of channel open times, determined indirectly from measurement of TRPV4 activity within a cluster of TRPV4 channels, revealed that the TRPV4 gain of function was caused by longer channel openings.

Conclusions These findings identify a novel TRPV4 mutation implicating TRPV4 and altered calcium homeostasis in the pathogenesis of osteonecrosis while reinforcing the importance of TRPV4 in bone diseases and vascular endothelium.

  • TRPV4
  • osteonecrosis of the femoral head
  • novel mutation
  • calcium channel

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.